Uterine leiomyosarcoma - A Singapore experience

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 39, Issue 2, 1999, Pages 246-248

  Soh, L T ^a,b   Chew, S H ^a   Ang, L ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; HUMAN; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; LEIOMYOSARCOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SINGAPORE; UTERUS MYOMA;

EID: 0032970464     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1999.tb03383.x     Document Type: Article

References (16)

1. Echt G. Jepson J, Steel J et al. Treatment of uterine sarcomas. Cancer 1990; 66: 35-39.
2. Salazar OM, Bonfiglio TA, Pattern SF et al. Uterine sarcoma: Natural history, treatment and prognosis. Cancer; 1978; 42: 1152-1160.
3. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Piere VK, Lewis JL Jr. Treatment of Uterine leiomyosarcoma. Obstet Gynecol 1988; 71: 845-850.
4. Omura GA, Blessing JA, Major F et al. A Randomised Clinical Trial of Adjuvant Adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study. J Clin Oncol 1985; 3: 1240-1245.
5. Bell SW, Kempson RL, Hendrickson MR. Problematic Uterine smooth Muscle Neoplasms. Am J Surg Pathol 1994; 18: 535-558.
6. Gadducci A, Landoni F, Sartori E et al. Uterine Leiomyosarcoma: Analysis of Treatment Failures and Survival. Gynecol Oncol 1996; 62: 25-32.
7. Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 1986; 67: 417-424.
8. Covens AL, Nisker JA, Chapman WB, Allen HH. Uterine sarcoma: an analysis of 74 cases. Am J Obstet Gynecol 1987; 156: 370-374.
9. Sorbe B. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas. Gynecol Oncol 1985; 20: 281-289.
10. Bai P, Sun J, Chao H. A clinical analysis of 153 uterine sarcomas. Chung Hua Fu Chan Ko Tsa Chih 1997; 32: 163-167.
11. Gadducci A, Fabrini MG, Bonuccelli A et al. Analysis of treatment failures in patients with early-stage uterine leiomyosarcoma. Anticancer Res 1995; 15:485-488.
12. Van Nagell JR Jr, Hanson MB, Donaldson ES, Gallion HH. Adjuvant vincristine, dactinomycin and cyclophosphamide therapy in stage I uterine sarcomas: A pilot study. Cancer 1986; 57: 1451-1454.
13. Marchese MJ, Liskow AS, Crum CP, McCaffrey RM, Frick HC. Uterine sarcomas: A clinicopathologic study, 1965-1981. Gynecol Oncol 1984; 18: 299-312.
14. Buchsbaum HJ, Lifshitz S, Blythe JG. Prophylactic chemotherapy in stage I and II uterine sarcoma. Gynecol Oncol 1979; 8: 346-348.
15. Hannigan EV, Freedman RS, Rutledge FN. Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol 1983; 15: 56-64.
16. O'Bryan RM, Luce JK, Talley RW, Gottlieb JA, Baker LH, Bonadonna G. Phase II evaluation of adriamycin in human neoplasia. Cancer 1973; 32: 1-8.